Advocate Health, Tenet Health, Mass General Brigham, Trinity Health and the Mayo Clinic are among the hospital and health system organizations that spent more than $1 million on federal government lobbying in 2024, according to study published in JAMA Health Forum.
Utah's Office of Artificial Intelligence Policy has approved demonstration projects testing AI for prescription drug renewals and certain dental diagnoses.
Primary care dementia program adds community health workers to streamline screening, workups, and family guidance for earlier Alzheimer’s care.
The FDA has approved Cosentyx as the first interleukin-17A (IL-17A) inhibitor approved for pediatric hidradenitis suppurativa.
Demonstration projects testing AI for prescription renewals and certain dental diagnoses have been approved by Utah's Office of Artificial Intelligence Policy.
Two surveys from West Health and Gallup find that healthcare affordability is a significant economic issue that affects nearly every aspect of life.
The state of Oregon has a commitment to keeping people covered and created a bridge program that extended Medicaid eligibility, Hunter noted.
Shorter hospital stays are a "good barometer" for quality and patient experience, says Risant Health CEO Jaewon Ryu.
Women going through perimenopause who feel lonely and socially isolated are more likely to report memory and cognitive difficulties than those who report neither, with the highest risk seen in those experiencing both.
In an overview of systematic reviews, researchers found that opioid analgesics have a role in the management of some acute pain conditions, such as postsurgical dental pain, with moderate evidence.
The costs are high, and the care system is designed for episodic intervention, “but then what happens?" asks Hunter.
AI-quantified breast arterial calcification independently predicts heart disease, adding value beyond standard risk scores and enabling earlier preventive care.
A study across B-cell lymphomas shows zanubrutinib delivers higher complete and overall response rates than acalabrutinib or ibrutinib, guiding BTK inhibitor choice.
Abarca Health CEO Jason Borschow says making prior authorization frictionless will require trusted frameworks for exchanging data and decision-making that both payers and providers align on.
Employers are bypassing insurers and contracting directly with providers. Direct contracting is not new, but soaring healthcare costs and the weight of fiduciary responsibility are whetting employers’ appetites for this option.
Risant Health comprises Geisinger Health in Pennsylvania and Cone Health in North Carolina. Risant CEO Jaewon Ryu, M.D., J.D., discussed how the two systems are prime candidates for adopting value-based care practices
The decision to withdraw the cancer drug Tazverik from the market was based on emerging data from a trial showing there is a risk of secondary hematological malignancies.
In a new study, researchers have identified six clinical and tumor variables that were significantly associated with a recurrence of melanoma.
James Ellison, M.D., M.P.H., and IBX’s Rodrigo Cerdá, M.D., M.P.H., back Jefferson Health primary care screening to catch dementia care needs early and coordinate support.
During the first part of a wide-ranging interview with MHE, Hunter discussed behavioral health and financial pressures on the Medicaid managed care plna he runs in Oregon.
The FDA has approved Sotyktu (deucravacitinib) as the first selective TYK2 inhibitor for adults with active psoriatic arthritis.
The state of Utah, which has a policy of encouraging AI, is allowing Doctronic, an artificial intelligence startup, to provide AI-powered automated prescription renewals. Critics express concern about "autonomous medical practice."
Phase 4 acute pain study shows Journavx helps more than 90% of plastic surgery patients achieve opioid-free recovery with strong ratings and mild side effects.
A study published in Substance Use and Addiction found that combining nicotine replacement therapy with a rewards-based contingency management program helped people with HIV achieve higher short-term smoking cessation rates than nicotine replacement therapy alone.
Jaewon Ryu, M.D., J.D., sees prevention and early recognition of disease as central to value-based care practices and programs at health systems.
Jaewon Ryu, M.D., J.D., CEO of Risant Health, discusses the role of accountable care organizations in supporting value-based practices at health systems.
